| Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial ST Harris, NB Watts, HK Genant, CD McKeever, T Hangartner, M Keller, ... Jama 282 (14), 1344-1352, 1999 | 3257 | 1999 |
| 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada JP Brown, RG Josse, ... Canadian Medical Association Journal 167 (10 suppl), S1-S34, 2002 | 1688 | 2002 |
| Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis KG Saag, R Emkey, TJ Schnitzer, JP Brown, F Hawkins, S Goemaere, ... New England Journal of Medicine 339 (5), 292-299, 1998 | 1586 | 1998 |
| The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women JA Kanis, A Odén, O Johnell, H Johansson, C De Laet, J Brown, ... Osteoporosis international 18 (8), 1033-1046, 2007 | 1492 | 2007 |
| Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus AA Khan, A Morrison, DA Hanley, D Felsenberg, LK McCauley, F O'Ryan, ... Journal of Bone and Mineral Research 30 (1), 3-23, 2015 | 1459 | 2015 |
| 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary A Papaioannou, S Morin, AM Cheung, S Atkinson, JP Brown, S Feldman, ... Canadian Medical Association Journal 182 (17), 1864-1873, 2010 | 1389 | 2010 |
| A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy D Liu, A Ahmet, L Ward, P Krishnamoorthy, ED Mandelcorn, R Leigh, ... Allergy, Asthma & Clinical Immunology 9 (1), 30, 2013 | 1250 | 2013 |
| Romosozumab in postmenopausal women with low bone mineral density MR McClung, A Grauer, S Boonen, MA Bolognese, JP Brown, ... New England Journal of Medicine 370 (5), 412-420, 2014 | 1239 | 2014 |
| Intravenous zoledronic acid in postmenopausal women with low bone mineral density IR Reid, JP Brown, P Burckhardt, Z Horowitz, P Richardson, U Trechsel, ... New England Journal of Medicine 346 (9), 653-661, 2002 | 1118 | 2002 |
| Canadian normative data for the SF-36 health survey WM Hopman, T Towheed, T Anastassiades, A Tenenhouse, S Poliquin, ... Canadian Medical Association Journal 163 (3), 265-271, 2000 | 972 | 2000 |
| Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis JD Adachi, WG Bensen, J Brown, D Hanley, A Hodsman, R Josse, ... New England Journal of Medicine 337 (6), 382-388, 1997 | 944 | 1997 |
| 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension HG Bone, RB Wagman, ML Brandi, JP Brown, R Chapurlat, ... The Lancet Diabetes & Endocrinology, 2017 | 914 | 2017 |
| Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 … JP Brown, RL Prince, C Deal, RR Recker, DP Kiel, LH De Gregorio, ... Journal of bone and mineral research 24 (1), 153-161, 2009 | 791 | 2009 |
| Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double‐blind, placebo‐controlled extension trial JD Adachi, KG Saag, PD Delmas, UA Liberman, RD Emkey, E Seeman, ... Arthritis & Rheumatology 44 (1), 202-211, 2001 | 718 | 2001 |
| A Meta‐Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX EV McCloskey, A Odén, NC Harvey, WD Leslie, D Hans, H Johansson, ... Journal of bone and mineral research 31 (5), 940-948, 2016 | 672 | 2016 |
| Recurrent Mutation of the Gene Encoding sequestosome 1 (SQSTM1/p62) in Paget Disease of Bone N Laurin, JP Brown, J Morissette, V Raymond The American Journal of Human Genetics 70 (6), 1582-1588, 2002 | 657 | 2002 |
| Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy S Wallach, S Cohen, DM Reid, RA Hughes, DJ Hosking, RF Laan, ... Calcified Tissue International 67 (4), 277-285, 2000 | 614 | 2000 |
| Vertebral Fractures Following Discontinuation of Denosumab: a Post‐hoc Analysis of the Randomized Placebo‐controlled FREEDOM Trial and its Extension SR Cummings, S Ferrari, R Eastell, N Gilchrist, JE Beck Jensen, ... Journal of Bone and Mineral Research, 2017 | 599* | 2017 |
| Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy DL Kendler, C Roux, CL Benhamou, JP Brown, M Lillestol, S Siddhanti, ... Journal of Bone and Mineral Research 25 (1), 72-81, 2010 | 580 | 2010 |
| Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study G Ioannidis, A Papaioannou, WM Hopman, N Akhtar-Danesh, ... Canadian Medical Association Journal 181 (5), 265-271, 2009 | 545 | 2009 |
